Diligence memo · auto-generated · as of July 2, 2026

Applied LifeSciences & Systems Poultry, Inc.

Applied LifeSciences & Systems Poultry, Inc. looks over-valued against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Applied LifeSciences & Systems Poultry, Inc. operates in Agriculture, based in Morrisville.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Applied LifeSciences & Systems Poultry, Inc. has raised $40M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).

Largest single filing: $28M on 2022-05-24.

Most recent recorded round closed around 2022-05-24.

Valuation (modeled)modeled

Provath models Applied LifeSciences & Systems Poultry, Inc. at approximately $197M (range $66M–$527M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Over-valued. Modeled value is 4.44× the median modeled value of Series B Agriculture companies in 2022–2024 (11 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Historic cadence: a new round about every 19 months.

Last raise 4.1 yr ago; this sector typically re-raises about every 11 months.

Silent for over 3× the sector's normal cadence.

The last round stepped up 8.0× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 93% of Agriculture peers (1056 compared).

Modeled value ranks above 93% of those peers.

Closest niche peers: CoverCress Inc., Alta Arbor Holdings, LLC, Jushi Holdings Inc., AmplifiedAg, Inc., Lowell Farms Inc..

Peoplefiled

14 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

Modeled above niche peers — valuation risk on entry.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.